- Home
- BHLB vs BLFS Comparison
BHLB vs BLFS Comparison
Compare BHLB & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHLB
- BLFS
- Stock Information
- Founded
- BHLB 1846
- BLFS 1987
- Country
- BHLB United States
- BLFS United States
- Employees
- BHLB N/A
- BLFS N/A
- Industry
- BHLB Banks
- BLFS Medical/Dental Instruments
- Sector
- BHLB Finance
- BLFS Health Care
- Exchange
- BHLB Nasdaq
- BLFS Nasdaq
- Market Cap
- BHLB 1.2B
- BLFS 1.1B
- IPO Year
- BHLB 2000
- BLFS 1989
- Fundamental
- Price
- BHLB $24.88
- BLFS $21.42
- Analyst Decision
- BHLB Hold
- BLFS Strong Buy
- Analyst Count
- BHLB 5
- BLFS 7
- Target Price
- BHLB $32.70
- BLFS $30.57
- AVG Volume (30 Days)
- BHLB 462.5K
- BLFS 586.3K
- Earning Date
- BHLB 07-17-2025
- BLFS 08-07-2025
- Dividend Yield
- BHLB 2.92%
- BLFS N/A
- EPS Growth
- BHLB 392.17
- BLFS N/A
- EPS
- BHLB 2.46
- BLFS N/A
- Revenue
- BHLB $431,403,000.00
- BLFS $87,762,000.00
- Revenue This Year
- BHLB $31.27
- BLFS $21.21
- Revenue Next Year
- BHLB $78.77
- BLFS $17.58
- P/E Ratio
- BHLB $10.02
- BLFS N/A
- Revenue Growth
- BHLB 33.05
- BLFS 34.80
- 52 Week Low
- BHLB $21.16
- BLFS $18.70
- 52 Week High
- BHLB $32.36
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- BHLB 49.76
- BLFS 43.67
- Support Level
- BHLB $24.46
- BLFS $20.50
- Resistance Level
- BHLB $25.25
- BLFS $22.07
- Average True Range (ATR)
- BHLB 0.47
- BLFS 0.99
- MACD
- BHLB 0.03
- BLFS -0.10
- Stochastic Oscillator
- BHLB 58.13
- BLFS 21.18
About BHLB Berkshire Hills Bancorp Inc.
Berkshire Hills Bancorp Inc is a holding company. It provides Commercial Banking, Retail Banking, Consumer Lending, Private Banking and Wealth Management services.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.